Bespoke Extracts, Inc. (BSPK) Bespoke Extracts, Inc. offers a range of cannabidiol (CBD) products sourced from hemp. Their diverse inventory includes various CBD formulations, such as those infused with manuka honey, as well as lotions and balms. Additionally, the company provides CBD extracts available in capsule form, topical applications, and edible gummies. These items are sold directly to consumers through their dedicated e-commerce website, bespokeextracts.com. The business, which changed its name from DiMi Telematics International, Inc. to Bespoke Extracts, Inc. in March 2017, is headquartered in Denver, Colorado.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Bespoke Extracts, Inc. OTC:BSPK Healthcare · Drug Manufacturers - Specialty & Generic
All Press Release SEC Filings News
SEC Filing ● Major ⚠ 6
BSPK: NT 10-Q · late filing
Bespoke Extracts, Inc. filed an NT 10-Q notifying the SEC that it cannot file its Form 10-Q for the quarter ended June 30, 2026 on time, and it does not expect to file even within the five-calendar-day grace period provided by Rule 12b-25(b).
The delay is compounding: the company has still not filed its Form 10-K for fiscal year 2025 or its Form 10-Q for the quarter ended March 31, 2026, and it confirmed it failed to file other required periodic reports during the preceding 12 months. The June 30 report cannot be completed until both earlier reports are done.
Preliminary unaudited figures show estimated revenue of approximately $505,000 for Q2 2026, up from $390,553 a year earlier on increased sales across product lines, but the company cannot yet estimate its net loss because closing procedures and review of operating expenses and accruals remain in process.
CEO Michael Feinsod, who also serves as CFO, signed the notification. Stacked delinquent filings and a blown grace-period expectation point to serious accounting and disclosure-control problems at this micro-cap issuer.
SEC NT 10-Q • 2mo ago SEC Filing ⚠ 4
BSPK: 8-K · debt financing
Bespoke Extracts, Inc. entered into a First Amendment to extend the maturity of its $410,000 Senior Secured Promissory Notes from June 30, 2026 to August 14, 2026. As part of the agreement, the interest rate for the extension period increased from 15% to 17% per annum, and the company agreed to issue unregistered shares equal to 10% of the outstanding principal as an extension fee.
The company expects to issue 287,719 shares of common stock to the noteholders within 30 days, valued at approximately $41,000 based on a 10-day VWAP of $0.1425. The shares will be issued in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.
SEC 8-K • 3mo ago AI analysis › SEC Filing ⚠ 3
BSPK: NT 10-Q · late filing
Bespoke Extracts, Inc. filed a Form 12b-25 notification on May 18, 2026, requesting additional time to file its Form 10-Q for the quarter ended March 31, 2026. The company cited the need for additional time to complete quarter-end closing procedures and finalize the compilation of financial information as the reason for the delay.
Despite the filing delay, the company disclosed that it anticipates a significant increase in results of operations. Specifically, Bespoke Extracts estimates that revenue for the first quarter of 2026 increased to approximately $373,000, up from $263,159 in the same quarter of the prior year. The company attributed this growth to increased sales across its product lines.
The company stated it is unable to provide a reasonable estimate of its net loss for the quarter because the final review of operating expenses and related accruals has not yet been completed. It expects to file the actual 10-Q within the five-calendar-day period permitted by Rule 12b-25.
SEC NT 10-Q • 5mo ago 
